Health Catalyst (NASDAQ:HCAT – Free Report) had its target price cut by Stifel Nicolaus from $15.00 to $12.00 in a report issued on Wednesday, Benzinga reports. They currently have a hold rating on the stock. Several other equities research analysts have also issued reports on the company. Evercore ISI dropped their price target on Health […]